Human FVII monoclonal antibodies binding the GLA domain and use thereof

Details for Australian Patent Application No. 2006286498 (hide)

Owner Novo Nordisk Health Care AG

Inventors Nicolaisen, Else Marie; Krarup, Janus; Pingel, Hans Kurt

Agent Shelston IP

Pub. Number AU-A-2006286498

PCT Pub. Number WO2007/026000

Priority 05107963.0 31.08.05 EP

Filing date 31 August 2006

Wipo publication date 8 March 2007

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/36 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/026000 Priority application(s): WO2007/026000

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286501-Implant

2006286497-Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with Staphylococcus aureus